COSMO PHARM NCOSMO PHARM NCOSMO PHARM N

COSMO PHARM N

No trades
See on Supercharts
Market capitalization
‪1.19 B‬CHF
‪1.31 M‬CHF
‪93.97 M‬CHF
‪7.36 M‬
Beta (1Y)
1.58

About COSMO PHARM N

CEO
Alessandro Della Chà
Headquarters
Dublin
Founded
2016
ISIN
NL0011832936
FIGI
BBG00CWX1FP3
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of COPN is 70.6 CHF — it has increased by 0.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange COSMO PHARM N stocks are traded under the ticker COPN.
COSMO PHARM N is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
COPN stock is 1.43% volatile and has beta coefficient of 1.58. Check out the list of the most volatile stocks — is COSMO PHARM N there?
One year price forecast for COSMO PHARM N has a max estimate of 110.4 CHF and a min estimate of 79.3 CHF.
Yes, you can track COSMO PHARM N financials in yearly and quarterly reports right on TradingView.
COPN stock has risen by 0.14% compared to the previous week, the month change is a 5.85% rise, over the last year COSMO PHARM N has showed a 30.26% increase.
COPN net income for the last quarter is ‪−133.11 K‬ CHF, while the quarter before that showed ‪1.46 M‬ CHF of net income which accounts for −109.09% change. Track more COSMO PHARM N financial stats to get the full picture.
Today COSMO PHARM N has the market capitalization of ‪1.13 B‬, it has increased by 2.90% over the last week.
Yes, COPN dividends are paid annually. The last dividend per share was 1.02 CHF. As of today, Dividend Yield (TTM)% is 1.45%. Tracking COSMO PHARM N dividends might help you take more informed decisions.
Like other stocks, COPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMO PHARM N stock right from TradingView charts — choose your broker and connect to your account.
COPN reached its all-time high on Jul 9, 2014 with the price of 193.7 CHF, and its all-time low was 11.0 CHF and was reached on Dec 12, 2008.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSMO PHARM N technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSMO PHARM N stock shows the buy signal. See more of COSMO PHARM N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on COSMO PHARM N future price: according to them, COPN price has a max estimate of 110.43 CHF and a min estimate of 79.27 CHF. Read a more detailed COSMO PHARM N forecast: see what analysts think of COSMO PHARM N and suggest that you do with its stocks.